Publications

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase Ii Study

AuthID
P-00W-G1F

Author(s)

Greco, C

Pares, O

Pimentel, N

Louro, V

Nunes, B

Kociolek, J

Stroom, J

Vieira, S

Mateus, D

Cardoso, MJ

Soares, A

Marques, J

Freitas, E

Coelho, G

Fuks, Z

Document Type

Article

Year published

2022

Published

in FRONTIERS IN ONCOLOGY, ISSN: 2234-943X

Volume: 12

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.3389/fonc.2022.863655

Pubmed: 35433469

Scopus: 2-s2.0-85128478927

Wos: WOS:000789127100001

Source Identifiers

ISSN: 2234-943X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase Ii Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase Ii Study

Useful Links

Get Help